Photo of Carmen Alonso

Carmen M Alonso, MD

    • Language
    • English
Dr. Alonso, a well-known and respected leader in child and adolescent psychiatry, is the Medical Director of the Pediatric Mood and Anxiety Disorders Program (PMAP), where she oversees all clinical services. A gifted and compassionate clinician, Dr. Alonso’s expertise lies in the diagnostic evaluation, coordination of psychotherapeutic/psychosocial interventions and management of targeted psychopharmacological treatments of the full range of pediatric psychiatric disorders, specializing in the inter-relationships of mood, anxiety and attention deficit/hyperactivity disorders. Her sensitive and skillful judgment uses evidence based treatments to guide decisions befitting the needs of individual clients while working with their families and involved schools/systems. Dr. Alonso received her B.A. in Psychology from NYU’s College of Arts & Sciences and her M.D. from New York Medical College, where she was elected into the Alpha Omega Alpha Honor Medical Society for clinical and academic excellence, graduating first in her class. She completed residency programs in pediatrics and general psychiatry at Mount Sinai. She also served as chief resident during her fellowship in child and adolescent psychiatry at Columbia, where she was distinguished for her clinical excellence in child psychiatry with the Edward J. Sachar Award. Dr. Alsonso is board certified in pediatrics by the American Board of Pediatrics and adult, child/adolescent, addiction and forensic psychiatry by the American Board of Psychiatry and Neurology. A dedicated educator, Dr. Alonso was Residency Training Director of Child and Adolescent Psychiatry at NYU School of Medicine for six years, mentored countless psychiatric residents, and earned Teacher of the Year awards across academic institutions while helping train a generation of child psychiatrists. Prior to her work at the Icahn School of Medicine at Mount Sinai, Dr. Alonso led clinical treatment teams across the spectrum of emergency, inpatient, consultation/liaison, school consultation and outpatient mental health services for children and adolescents at Columbia Presbyterian Medical Center (CPMC), Schneider Children’s Hospital at Long Island Jewish Medical Center (LIJMC) and NYU/Bellevue. Included among these were Deputy Director of Clinical Services at the Child and Adolescent Psychiatry Clinic and the Director of On-site School Mental Health at CPMC; Physician-in-Charge of the Pediatric Psychiatry Consultation Liaison Service and Inpatient Psychiatric Services at Schneider Children’s Hospital at LIJMC; and Director of Pediatric Psychiatry Emergency Services and the Child and Adolescent Psychiatry Clinic at Bellevue Hospital Center. Dr. Alonso has been a co-investigator in multiple NIMH-funded studies, serving as the supervising psychopharmacologist at the LIJMC site of the Multimodal Treatment Study of Children with ADHD (MTA), the largest and most comprehensive treatment study of ADHD that has been conducted to date; as well as examining the efficacy of omega-3 fatty acids (Omega-3FA) in Tourette’s Disorder and the efficacy and neurochemical effects of Omega-3FA in adolescent major depression. Dr. Alonso’s advocacy in protecting research subjects’ safety led to serving on the NYU School of Medicine’s Institutional Review Board for twelve years. She is actively involved in PMAP’s research on the neurobiological correlates of mood and anxiety disorders in the pediatric population with the aim to improve identification/refine diagnosis to facilitate the development of personalized and more effective treatments.